ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43421
0.00%
Bitcoin
97,009.51
-0.20%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. Channel Therapeutics Corporation (CHRO) Share Price

Channel Therapeutics Corporation

Channel Therapeutics Corporation (CHRO)

AMEX
0.6435
-0.0095
(-1.45%)
Closed December 22 3:00PM
Delayed by 15 minutes
0.6203
-0.0232
(-3.61%)
After Hours: 4:06PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.6203
Bid
-
Ask
-
Volume
162,100
0.562 Day's Range 0.65
0.45 52 Week Range 6.00
Market Cap
3.739M
Previous Close
0.653
Open
0.646
Last Trade
501
@
0.6435
Last Trade Time
Financial Volume
US$ 101,603
VWAP
0.626792
Average Volume (3m)
161,435
Shares Outstanding
6,028,011
Dividend Yield
-
PE Ratio
-0.52
Earnings Per Share (EPS)
-1.22
Revenue
-
Net Profit
-7.38M

About Channel Therapeutics Corporation

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
channeltherapeutics.com
Headquarters
Reno, Nevada, USA
Founded
-
Channel Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CHRO. The last closing price for Channel Therapeutics was US$0.65. Over the last year, Channel Therapeutics shares have traded in a share price range of US$ 0.45 to US$ 6.00.

Channel Therapeutics currently has 6,028,011 shares outstanding. The market capitalization of Channel Therapeutics is US$3.94 million. Channel Therapeutics has a price to earnings ratio (PE ratio) of -0.52.

Ask ADVFN Intelligence (AI)

CHRO Latest News

More News

Chromocell Announces Amendment to Stock Repurchase Plan

FREEHOLD, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

October 24 2024
GlobeNewswire Inc.

Chromocell to Participate in the Virtual Investor Lunch Break Series

FREEHOLD, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

July 15 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

June 18 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

May 15 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 15 2024
Edgar (US Regulatory)

Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024

FREEHOLD, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

May 13 2024
GlobeNewswire Inc.

Chromocell Issues Letter to Stockholders from Chief Executive Officer

FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

April 09 2024
GlobeNewswire Inc.

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

FREEHOLD, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

March 21 2024
GlobeNewswire Inc.

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

FREEHOLD, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

March 18 2024
GlobeNewswire Inc.

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment...

March 11 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0691-10.02320858720.68940.68940.56332102990.59961457CS
40.00130.2100161550890.6190.880.55131638560.6990816CS
12-0.3496-36.04495308790.96991.040.451614350.73252942CS
26-0.7897-56.00709219861.411.750.45996750.80642223CS
52-5.3797-89.6616666667660.45691291.06548021CS
156-5.3797-89.6616666667660.45691291.06548021CS
260-5.3797-89.6616666667660.45691291.06548021CS

CHRO - Frequently Asked Questions (FAQ)

What is the current Channel Therapeutics share price?
The current share price of Channel Therapeutics is US$ 0.6203
How many Channel Therapeutics shares are in issue?
Channel Therapeutics has 6,028,011 shares in issue
What is the market cap of Channel Therapeutics?
The market capitalisation of Channel Therapeutics is USD 3.94M
What is the 1 year trading range for Channel Therapeutics share price?
Channel Therapeutics has traded in the range of US$ 0.45 to US$ 6.00 during the past year
What is the PE ratio of Channel Therapeutics?
The price to earnings ratio of Channel Therapeutics is -0.52
What is the reporting currency for Channel Therapeutics?
Channel Therapeutics reports financial results in USD
What is the latest annual profit for Channel Therapeutics?
The latest annual profit of Channel Therapeutics is USD -7.38M
What is the registered address of Channel Therapeutics?
The registered address for Channel Therapeutics is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501
What is the Channel Therapeutics website address?
The website address for Channel Therapeutics is channeltherapeutics.com
Which industry sector does Channel Therapeutics operate in?
Channel Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MGLDMarygold Companies Inc
US$ 2.053
(48.77%)
128.45k
MINFT Limited
US$ 7.25
(44.22%)
948.89k
CTMCastellum Inc
US$ 0.578
(41.01%)
8.94M
KULRKULR Technology Group Inc
US$ 2.885
(28.79%)
75.72M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 12.49
(22.81%)
64.96M
BATLBattalion Oil Corporation
US$ 1.3499
(-44.56%)
1.63M
NVOXDefiance Daily Target 2x Long Nvo ETF
US$ 11.5991
(-35.47%)
406.44k
UVIX2x Long VIX Futures ETF
US$ 3.83
(-29.07%)
70.31M
TPETTrio Petroleum Corp
US$ 1.10
(-25.17%)
2.79M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 19.235
(-23.06%)
21.21M
SPYSPDR S&P 500
US$ 591.15
(0.86%)
121.43M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6.1628
(-3.25%)
114.37M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 27.30
(3.80%)
107.24M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.435
(7.27%)
93.88M
KULRKULR Technology Group Inc
US$ 2.885
(28.79%)
75.32M

Discussion

View Full Feed
Bull_Dolphin Bull_Dolphin 27 seconds ago
Good morning kk. Looks like your going to have a white Christmas:

https://www.wpc.ncep.noaa.gov/basicwx/day0-7loop.html
ElectricMountain53 ElectricMountain53 2 minutes ago
Doesn't take away the fact lots of belgians have invested in the worst performing stocks over the last decade. Niocorp, Lightwave to name a few LOL
LWLG
Frankestin Frankestin 8 minutes ago
Just think, in July, when was this offer closed, it was at 0.50 and there was no 74 day letter imminent!
TNXP
ksquared ksquared 12 minutes ago
Wow! Great way to start the day. Thanks and GM, Bull.
walterc walterc 16 minutes ago
for your information

Jeunke is Dutch nott (lol) Belgian.
LWLG
ksquared ksquared 17 minutes ago
Good Morning, Mr. Gmenfancicle. We're in the tropics compared to you. We're still in double digits.
The joy of single ones arrives tonight. Fortunately we're due for a warm up on Tuesday.
To me, this snow was beautiful and easily managed. It lent the perfect atmo
Bull_Dolphin Bull_Dolphin 18 minutes ago
Tree topper:

https://x.com/KarluskaP/status/1870453214614892608
copytele copytele 20 minutes ago
https://youtu.be/QmJGGNZ06RY
RGTI
ksquared ksquared 22 minutes ago
GM, MG. So glad to read you got yourself a room with HEAT.
It's a frosty 14° up here in the NW corner of nj. Word has it we'll get up to a toasty 24 today and down to 4 tonight. Sleeping in your truck would be insanity.
Stay safe and warm.
Peter J Peter J 24 minutes ago
Mr. "beat around the bush" ...

.... looking out for the gullible investor here, on the, by it OTC Markets Group itself labelled "Buyer Beware!!" 'Skull and Bones' Expert market.

*There is no interest in ERHC, not even by insiders
*There is no possibility to buy t
ERHE
ksquared ksquared 30 minutes ago
Ana Kasparian of ‘Young Turks’ explodes at possibility of Harris becoming California governor: ‘I’m gonna move!’
By Alexander Hall, Fox News Published Dec. 21, 2024, 11:46 a.m. ET “This state cannot survive another incompetent Democrat leading it,” Kasparian said. “No, we just c
edbi46 edbi46 34 minutes ago
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!!!!

No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 13 years, from Oct. 2011 and counting?? ), did/will do any d
MCF WBA
Investor2014 Investor2014 36 minutes ago
Yes the centralised procedure on approval applies to all EU countries, but it is up to each country to decide whether and how to make an approved treatment available through their national healthcare system and negotiate pricing.
AVXL
Bull_Dolphin Bull_Dolphin 57 minutes ago
We restock during Easter sales. Shrink wrapped with our FoodSaver, they keep quite nicely.
jtaylor042 jtaylor042 1 hour ago
Well you're one who knows where the lifeboat is and...yet I still find you here.
NWBO
vuletini vuletini 1 hour ago
Built it and they will come....
SHIBUSD
jeunke22 jeunke22 1 hour ago
I have seen your recommendations across a number of boards. I am very aware of the risk involved when investing in start ups. Thanks for reminding me. I wil put you back where you belong! Bye bye!
LWLG
SteveSchiets SteveSchiets 2 hours ago
Yp, I know what to post to get your blood going. That's just a bit funny. I won't do it again. Of course you can post whatever you want.
This board is not swamped by newcomers, so I guess you don't have a lot of work. We are all adults here, no daily warnings is needed, imo.
I hold 7
SEV
biosectinvestor biosectinvestor 2 hours ago
Obviously not my point. You say stuff like this, yet either you never sell or you never really owned. Making noisy exits before they sell, for years, makes very little sense for real owners. Shorts and swing traders are frequently “exiting”,swing traders claim to do so, before news. And then want
NWBO
jeunke22 jeunke22 2 hours ago
Hope you understand that the $ 120 includes the PIC part in the transceiver market as well.
Conclusion: comparison with UDC between 40 and 120.
I will be happy with $ 40+ !
LWLG
LoveThemStocks LoveThemStocks 2 hours ago
I was told the same that you were told about falling in love with any subpenny and penny stock, but the reason for that is that many of the subpenny and penny stocks are scam companies. I'm in two companies right now that aren't scam stocks and both of them happens to be Tonix and Amprius. Tonix is
TNXP
TurboMountain96 TurboMountain96 2 hours ago
Osisko went for 4.90 a share, we are trading at 0.12 currently, say we sold at 1.50 a share worst ways I think we would love a 12x 😀
FFMGF

Your Recent History

AMEX
CHRO
Channel Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads